We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Updated: 12/31/1969
Myocardial Ischemia and Transfusion Pilot
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Vitamin D and Omega-3 Trial (VITAL)
Updated: 12/31/1969
Vitamin D and Omega-3 Trial (VITAL)
Status: Enrolling
Updated: 12/31/1969
Vitamin D and Omega-3 Trial (VITAL)
Updated: 12/31/1969
Vitamin D and Omega-3 Trial (VITAL)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Regulation of Endothelial Progenitor Cells by Short-Term Exercise
Updated: 12/31/1969
Regulation of Endothelial Progenitor Cells by Short-Term Exercise
Status: Enrolling
Updated: 12/31/1969
Regulation of Endothelial Progenitor Cells by Short-Term Exercise
Updated: 12/31/1969
Regulation of Endothelial Progenitor Cells by Short-Term Exercise
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX
Updated: 12/31/1969
Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis in the Aortic Position, Model 3300TFX
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ranolazine and Pulmonary Hypertension
Updated: 12/31/1969
Effects of Ranolazine in Patients With Angina Due to Right Ventricular Ischemia in Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Ranolazine and Pulmonary Hypertension
Updated: 12/31/1969
Effects of Ranolazine in Patients With Angina Due to Right Ventricular Ischemia in Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Counseling Older Adults to Control Hypertension
Updated: 12/31/1969
Counseling Older Adults to Control Hypertension
Status: Enrolling
Updated: 12/31/1969
Counseling Older Adults to Control Hypertension
Updated: 12/31/1969
Counseling Older Adults to Control Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Updated: 12/31/1969
Optimizing Cooling Strategies at < 6 Hours of Age for Neonatal Hypoxic-Ischemic Encephalopathy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters
Updated: 12/31/1969
A Comparative Clinical Trial to Assess the Accuracy of the TensorTip, a Novel Non Invasive Device for the Measurement of Physiological and Blood Chemistry Parameters
Status: Enrolling
Updated: 12/31/1969
A Comparative Clinical Trial of the TensorTip, a Novel Non Invasive Device for Measurement Blood Parameters
Updated: 12/31/1969
A Comparative Clinical Trial to Assess the Accuracy of the TensorTip, a Novel Non Invasive Device for the Measurement of Physiological and Blood Chemistry Parameters
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
EXCEL Clinical Trial
Updated: 12/31/1969
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
Status: Enrolling
Updated: 12/31/1969
EXCEL Clinical Trial
Updated: 12/31/1969
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
Updated: 12/31/1969
The RIGHT Study: Risk Stratification With Image Guidance of HMG Coa Reductase Inhibitor Therapy
Status: Enrolling
Updated: 12/31/1969
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
Updated: 12/31/1969
The RIGHT Study: Risk Stratification With Image Guidance of HMG Coa Reductase Inhibitor Therapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Exercise for Women With Peripheral Arterial Disease
Updated: 12/31/1969
Exercise for Women With Peripheral Arterial Disease
Status: Enrolling
Updated: 12/31/1969
Exercise for Women With Peripheral Arterial Disease
Updated: 12/31/1969
Exercise for Women With Peripheral Arterial Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
Updated: 12/31/1969
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
Status: Enrolling
Updated: 12/31/1969
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
Updated: 12/31/1969
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Updated: 12/31/1969
Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern
Status: Enrolling
Updated: 12/31/1969
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Updated: 12/31/1969
Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Updated: 12/31/1969
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Aspirin-treated Subjects With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Updated: 12/31/1969
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Aspirin-treated Subjects With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Updated: 12/31/1969
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Aspirin-treated Subjects With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Updated: 12/31/1969
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Aspirin-treated Subjects With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Updated: 12/31/1969
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Aspirin-treated Subjects With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
Updated: 12/31/1969
The Influence of Smoking Status on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Aspirin-treated Subjects With Stable Coronary Artery Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
Updated: 12/31/1969
ACRIN 4701 RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Utilization of Diagnostic Examinations
Status: Enrolling
Updated: 12/31/1969
Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
Updated: 12/31/1969
ACRIN 4701 RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Utilization of Diagnostic Examinations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
Updated: 12/31/1969
ACRIN 4701 RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Utilization of Diagnostic Examinations
Status: Enrolling
Updated: 12/31/1969
Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
Updated: 12/31/1969
ACRIN 4701 RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Utilization of Diagnostic Examinations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
Updated: 12/31/1969
ACRIN 4701 RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Utilization of Diagnostic Examinations
Status: Enrolling
Updated: 12/31/1969
Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations
Updated: 12/31/1969
ACRIN 4701 RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Utilization of Diagnostic Examinations
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Investigational Device Exemption Study to Determine the Safety and Efficacy of the Astron and Pulsar Stents
Updated: 12/31/1969
The Treatment of Iliac and Femoral Atherosclerotic Lesions Using the Self-expanding Astron and Pulsar Stents
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials